110
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Cotreatment with Aspirin and Azole Drugs Increases Sensitivity of Candida albicans in vitro

, , , , , , & show all
Pages 2027-2038 | Published online: 02 Jun 2021

Figures & data

Table 1 The Clinical Features of the Patients Where the Strains Were Isolated

Table 2 The Values of Minimum Inhibitory Concentration (MIC50) Under Planktonic Conditions When Aspirin (ASA) and Fluconazole (FCA) Were Used

Table 3 The Values of Minimum Inhibitory Concentration (MIC50) Under Biofilm Conditions When Aspirin (ASA) and Fluconazole (FCA) Were Used

Table 4 The Interactions Between Aspirin (ASA) and Fluconazole (FCA), Itraconazole (ITR) or Voriconazole (VRC) Under Different Conditions

Figure 1 Time–growth curves of Candida albicans ZY23. Time–growth curves of ZY23 treated with (A) fluconazole (FCA) (B) itraconazole (ITR) or (C) voriconazole (VRC) alone or in combination with different concentrations of aspirin (ASA).

Figure 1 Time–growth curves of Candida albicans ZY23. Time–growth curves of ZY23 treated with (A) fluconazole (FCA) (B) itraconazole (ITR) or (C) voriconazole (VRC) alone or in combination with different concentrations of aspirin (ASA).

Figure 2 Time-kill curves of Candida albicans ZY23 treated with (A) fluconazole (FCA) (B) itraconazole (ITR), and (C) voriconazole (VRC) alone or combination.

Figure 2 Time-kill curves of Candida albicans ZY23 treated with (A) fluconazole (FCA) (B) itraconazole (ITR), and (C) voriconazole (VRC) alone or combination.